Alyeska Investment Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.9M | Sell |
513,311
-391,689
| -43% | -$27.4M | 0.13% | 200 |
|
2025
Q1 | $66.5M | Sell |
905,000
-2,122,511
| -70% | -$156M | 0.27% | 106 |
|
2024
Q4 | $198M | Buy |
3,027,511
+2,083,645
| +221% | +$137M | 0.75% | 20 |
|
2024
Q3 | $73.5M | Sell |
943,866
-1,475,029
| -61% | -$115M | 0.38% | 91 |
|
2024
Q2 | $189M | Sell |
2,418,895
-376,786
| -13% | -$29.4M | 1.08% | 16 |
|
2024
Q1 | $189M | Buy |
2,795,681
+2,220,684
| +386% | +$150M | 1.17% | 8 |
|
2023
Q4 | $38.7M | Sell |
574,997
-826,859
| -59% | -$55.7M | 0.26% | 123 |
|
2023
Q3 | $94.9M | Buy |
+1,401,856
| New | +$94.9M | 0.64% | 38 |
|
2020
Q3 | – | Sell |
-22,838
| Closed | -$1.21M | – | 463 |
|
2020
Q2 | $1.21M | Buy |
+22,838
| New | +$1.21M | 0.02% | 374 |
|
2018
Q4 | – | Sell |
-26,285
| Closed | -$1.04M | – | 322 |
|
2018
Q3 | $1.04M | Buy |
+26,285
| New | +$1.04M | 0.01% | 321 |
|
2018
Q1 | – | Sell |
-2,357,230
| Closed | -$81.8M | – | 406 |
|
2017
Q4 | $81.8M | Buy |
+2,357,230
| New | +$81.8M | 0.65% | 51 |
|